SAN ANTONIO – The U.S. Food and Drug Administration has granted Xenex Disinfection Services a De Novo authorization for its LightStrike+ device. That decision is expected to significantly drive up demand for the San Antonio-based company’s germ-zapping robots. The Xenex machines utilize high-intensity, broad-spectrum ultraviolet light to reduce potentially deadly…Read More
Related Posts
JEGI CLARITY Has Advised Nomura Research Institute NRI on its Sale of BrierleyPartners to Capillary…
NEW YORK, April 10, 2023 /PRNewswire/ -- Nomura Research Institute (TSE:4307), advised by JEGI CLARITY, has sold Brierley+Partners to Capillary Technologies.
LightLab 3 Cannabis Analyzer Chosen by FDA to Enhance Consumer Safety and Regulation in the…
NEW LONDON, N.H., Aug. 18, 2023 /PRNewswire/ -- Orange Photonics, a pioneer in revolutionizing HPLC technology, is proud to announce that the US Food and Drug Administration (FDA) has selected…
89bio to Participate in the HC Wainwright 25th Annual Global Investment Conference
SAN FRANCISCO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver…
